O'Shares Investment Advisers’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-63,237
Closed -$18.1M 132
2022
Q1
$18.1M Buy
63,237
+3,532
+6% +$909K 1.43% 14
2021
Q4
$16.5M Buy
59,705
+4,394
+8% +$1.11M 1.18% 18
2021
Q3
$12.8M Sell
55,311
-18,296
-25% -$4.52M 0.94% 20
2021
Q2
$16.9M Buy
73,607
+2,031
+3% +$408K 1.19% 16
2021
Q1
$13.4M Sell
71,576
-139
-0.2% -$27.2K 0.99% 22
2020
Q4
$12.1M Buy
71,715
+6,588
+10% +$984K 0.92% 28
2020
Q3
$9.64M Buy
65,127
+36,088
+124% +$5.59M 1.01% 25
2020
Q2
$4.77M Sell
29,039
-23,934
-45% -$3.67M 0.6% 37
2020
Q1
$7.35M Sell
52,973
-44
-0.1% -$6.05K 1.31% 18
2019
Q4
$6.97M Buy
53,017
+3,727
+8% +$432K 0.96% 26
2019
Q3
$5.51M Buy
49,290
+7,386
+18% +$822K 0.83% 29
2019
Q2
$4.64M Buy
41,904
+2,448
+6% +$288K 0.74% 32
2019
Q1
$5.12M Buy
39,456
+1,152
+3% +$140K 0.87% 26
2018
Q4
$4.43M Buy
+38,304
New +$4.28M 0.85% 29

Other funds holding LLY

O'Shares Investment Advisers's LLY Position: Q2 2022 in Review

O'Shares Investment Advisers sold out of Eli Lilly (LLY) in Q2 2022, closing a stake of 63,237 shares — an estimated $18.1M sold.

O'Shares Investment Advisers first reported a position in LLY in Q4 2018 and held it in 14 quarters. The position peaked at $18.1M in Q1 2022. 2,445 funds tracked by Wall St. Rank hold LLY as of Q2 2022.

  • O'Shares Investment Advisers reported no remaining Eli Lilly position as of Q2 2022 after selling out during the quarter.
  • O'Shares Investment Advisers sold 63,237 Eli Lilly shares in Q2 2022, an estimated $18.1M.
  • O'Shares Investment Advisers first reported a position in Eli Lilly in Q4 2018 and held it in 14 quarters.
  • O'Shares Investment Advisers's Eli Lilly position peaked at $18.1M in Q1 2022.
  • 2,445 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2022.

Based on O'Shares Investment Advisers's 13F filing for Q2 2022.